Buy Vertex PharmaceuticalsShort Term Trading Advice by Naranj Capital
Buy Vertex Pharmaceuticals
● Buy Range- 475 - 480
● Target- 500 - 505
● StopLoss- 460
● Potential Return- 5-6%
● Duration- 12-14 Trading Days
VERTEX
Vertex’s Stock Heads for All-Time HighVertex Pharmaceuticals Inc. shares were on track for an all-time high Wednesday after the company released new data from a trial of its investigational non-opioid pain medicine.
The stock jumped more than 10% Wednesday morning, on pace for its largest percentage gain in more than three years, and was set to cross the $100 billion market-capitalization threshold for the first time.
The company’s experimental pain medicine VX-548 produced statistically significant, clinically meaningfully reductions in pain intensity in people with diabetic peripheral neuropathy, a type of nerve damage that can affect people with diabetes, Vertex said in a release.
The pain control seen with the drug appears comparable to the “gold standard” pain medicine pregabalin, which is marketed by Viatris Inc. under the brand name Lyrica, Evercore ISI analyst Liisa Bayko wrote in a report Wednesday. Evercore analysts raised their price target on Vertex shares to $405, from $389 previously.
The new data on the pain medicine “looks at least as good as or better than investor expectations,” Jefferies analysts said in a note Wednesday.
Vertex is working to quickly advance the treatment to Phase 3 studies in diabetic peripheral neuropathy, Vertex’s chief medical officer, Dr. Carmen Bozic, said in a statement. Phase 3 results from a trial of the drug in acute pain are expected in the first quarter of next year.
Vertex shares have gained 37% in the year to date, while the S&P 500 is up 21%.
NASDAQ:VRTX is trading above the 50, 100 & 200-day Moving Averages indicating the trend might continue.
GBPUSD As predicted, the selling pressure continued, marked with fundamental outlook from both currencies. How far can price go in this direction?
Vertex - rising wedge patternWhat we can see in the chart is a rising wedge pattern. We expect the price to break down from the rising wedge formation.
It may take a little bit more time since the price is still consolidating inside the wedge.
You should enter short position when/if the price breaks down of the wedge with a volume surge.
Do not forget to put a stop loss once you enter the trade.
Stop loss should be placed above the wedge.
Structural Shift in XAUUSDPossible change in character in Gold which could see a profit in pips of 100pips in its minimum. Close look on multi timeframe analysis could see price move go even a bit higher but this isn't completely backed with the evident structures provided yet. Do share your idea if you have something else
Vertex PharmaNASDAQ:VRTX is on a verge of a breakout. AMEX:XPH is also staging a recovery, but still trading below key levels. For now, the focus in on a NASDAQ:VRTX look position.
EUR/USD on long positionseems eur/usd has made a double pattern and expected to start an upward trend
US30 FOLLOW UPFollow up on the previous post on US30. Entry picked nicely for a possible continuation.
EURAUD, D1 OUTLOOKDaily change of character for a possible buy positions on EURAUD. Could the story hold true?
Drop your view on the comment
VRTX (Vertex Pharmaceuticals) Heading HigherVolume Profile shows virtually no volume transacted between current price and $260, so price should arrive at $260 without much trouble.
SOL OUTLOOK 1H TFSo far, a change of character is seen on the H1 with $157 being a potential supply zone. If market is bullish enough to break this zone then we'd see market make higher highs following a mitigation. However if not broken, then we could see market go lower
$VRTX WEAKLY CHART #VERTEX #Stock #Stocks #Stockmarketlooks like is getting ready to lift up , waiting for retest #Stock #Stocks #Stockmarket
VRTX Long Chance on ChannelNASDAQ:VRTX had an ongoing negative Trend since July 2020. It broke the negative Trend 2 days ago.
For me its a very good chance and low price for VRTX.
strong up move with good volume crossing the negative trend
crossed EMA200 and MA200 on daily chart and also on weeky chart
still above EMA200 and MA200 on monthly chart
still in positive trend since 2008
good position in the market
good cashflow for the next years, even if products are failing
VERTEXCHARTS | EURJPY TRADE IDEAEURJPY has not hit the support level in the daily timeframe chart.
Confirm a reversal for a bullish position.
$VRTX #VERTEXI like this RETEST TO PUSH HIGHER AND MAYBE FILL THE GAP THE ORANGE AREA , The risk reward is so far good
NZDUSD BEARISH IDEAA Liquidity is Mitigated and an Impulse Move broke the structure, and i then waited for a confirmation that indeed the uptrend Is over and therefore a downtrend is clearly seen.
*the Entry OB is refined
Missed vertex entryThis was a missed trade on GBPUSD, based on the vertex style of smart money concert
VERTEXCHARTS | USDCHF CHART ANALYSISUSDCHF on the 4Hr Timeframe has formed an ascending triangle.
The pair is growing after hitting the support zone of the triangle.
Like and Comment to support this idea.
EURUSD PRO ANALYSIS,NAKED CHARTBias is bullish for EURUSD a lot of unfilled orders lying around 1.21000 area which makes it our target for short term profit taking. Stay winning gents and ladies.
As always dont stay married to your bias.
VERTEXCHARTS | GOLD TRADE IDEAGold has broken the resistance line of the descending channel.
The pair has formed an uptrend from the support of the descending channel.
Like and comment to Support this Idea
VERTEXCHARTS | USDCAD TRADE IDEAUSDCAD is consolidating above the support level in a growing channel.
The level is strong, maybe only a false breakout, after capturing liquidity, the price can be returned back beyond the level for further growth.
The pair is bound to grow from the support level.
Like and Comment to Support this idea.
